#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    PIK3CA related overgrowth spectrum Myxoid liposarcoma Oesophageal adenocarcinoma Ocular lymphoma Castleman's disease Endocrine ophthalmopathy MELAS syndrome Idiopathic inflammatory myopathy Small cell lung cancer extensive stage Brain stem glioma Transitional cell carcinoma Infection in an immunocompromised host Atypical haemolytic uraemic syndrome Osteomyelitis Neuroendocrine tumour of the lung More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I Glycogen storage disease type I – Trials in Disease Fabry’s disease – Basic Information Isodicentric chromosome 15 syndrome – Life with Disease Undifferentiated sarcoma – Diagnostics Alagille syndrome – Diagnostics Marfan’s syndrome – Life with Disease Medulloblastoma Alveolar rhabdomyosarcoma – Treatment Thrombotic thrombocytopenic purpura – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dsimc ICEF15 Emavusertib Indacaterol Acetate PIPOTIAZINE Zipalertinib Azd0305 AGANIRSEN Trazodone Corylus Avellana L. Levomepromazine Hydrochloride Alitretinoin Tiaprofenic Acid Interleukin-2 Florbetaben (18F) Vibozilimod Eteplirsen Calcipotriol Cenerimod Florbetapir (18F) More therapies…

    Learn about Your Condition

    Precocious puberty Chondrocalcinosis Metastatic gastric cancer White matter lesion Thrombocytosis Normal pressure hydrocephalus Abdominal pain Skin papilloma Oral herpes Plasma cell myeloma refractory Laryngeal cancer stage I Viral myocarditis Infectious pleural effusion Post-traumatic stress disorder Eye inflammation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z…

Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o.

Ul. Marcelinska 92, Poznan, 60-324, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Austria Belgium Bulgaria Czechia France Germany +7

  • Study on Tulisokibart for Treating Moderate to Severe Crohn’s Disease in Adults

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Tulisokibart
    Austria Belgium Croatia Czechia Denmark Finland +15

  • Study on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Cenerimod
    Czechia Germany Poland Portugal Spain

  • Study of AZD7798 compared to placebo in patients with moderate to severe Crohn’s disease

    Not recruiting

    2 1
    Investigated Drugs:
    • Azd7798
    Austria Belgium Bulgaria Croatia France Germany +8

  • A study to test if tibulizumab works and is safe for adults with systemic sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Hungary Poland Romania Spain
Previous Page
1 … 5 6 7

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!